Your cart
Your cart is empty.HEALTH NEWS
Study Title:
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pai
Study Abstract
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.
Study Information
Mediators Inflamm. 2013;2013:328797. doi: 10.1155/2013/328797. Epub 2013 Feb 25. PMID: 23533304; PMCID: PMC3596927.